16-30 of 166
Reshaping Dialysis Care: How New Payment Models Focus on Quality and Outcomes
Clinician's RoundtableReshaping Dialysis Care: How New Payment Models Focus on Quality and Outcomes
Bridging Gaps in Kidney Care: How to Improve Referrals, Transitions, and Coordination
Clinician's RoundtableBridging Gaps in Kidney Care: How to Improve Referrals, Transitions, and Coordination
Identifying Gaps in Kidney Care for People Living with HIV: Insights from a Survey
Clinician's RoundtableIdentifying Gaps in Kidney Care for People Living with HIV: Insights from a Survey
Improving Risk Stratification in Lupus Nephritis: The Role of Urinary Biomarkers
Living RheumImproving Risk Stratification in Lupus Nephritis: The Role of Urinary Biomarkers
Optimizing Patient Outcomes in CKD & T2D Care With CONFIDENCE
EndocrinologyOptimizing Patient Outcomes in CKD & T2D Care With CONFIDENCE
Optimizing IgAN Care: Sparsentan’s Role Amid the Latest KDIGO Guideline Updates
NephrologyOptimizing IgAN Care: Sparsentan’s Role Amid the Latest KDIGO Guideline Updates
- advertisement
Rethinking Lupus Nephritis: Targeting Immune Dysfunction
Living RheumRethinking Lupus Nephritis: Targeting Immune Dysfunction
Enhancing IgAN Care: The Importance of a Proactive Approach
Clinician's RoundtableEnhancing IgAN Care: The Importance of a Proactive Approach
Navigating Treatment Goals in IgAN: The Impact of ET-1 and Ang II
Clinician's RoundtableNavigating Treatment Goals in IgAN: The Impact of ET-1 and Ang II
Deciphering the Link: Proteinuria and eGFR Dynamics in IgAN and FSGS
Clinician's RoundtableDeciphering the Link: Proteinuria and eGFR Dynamics in IgAN and FSGS
Proteinuria in CKD Progression: Understanding Its Role and Monitoring Strategies
Clinician's RoundtableProteinuria in CKD Progression: Understanding Its Role and Monitoring Strategies
Innovations in IgAN Care: Addressing Challenges with Therapeutic Advances
Clinician's RoundtableInnovations in IgAN Care: Addressing Challenges with Therapeutic Advances
- advertisement
Moving Beyond Immunosuppressive Therapy in IgAN
Clinician's RoundtableMoving Beyond Immunosuppressive Therapy in IgAN
From Infusion Chair to Clinic Visit: How Subcutaneous Nivolumab May Simplify RCC Care
Project Oncology®From Infusion Chair to Clinic Visit: How Subcutaneous Nivolumab May Simplify RCC Care
Difelikefalin: Managing CKD-aP for Improved Quality of Life
NephrologyDifelikefalin: Managing CKD-aP for Improved Quality of Life
